ARCHIVES

Gleevec Approval Sets Record For FDA Review: 73 Days

This article is from The Cancer Letter archive.

Vol. 24 No. 5 | May 25, 2001

Download PDF Visit The Full Archive

Related Articles

Therapeutic Modalities Improve Patient Quality of Life In Trials

February 27, 2004

SWOG Study To Test Predictive Value Of Circulating Tumor Cells In Breast Cancer

October 27, 2006

Oncology Management: US Oncology To Conduct Up To 5 Studies Of PG-TXL In Colorectal, Lung Cancers

June 1, 2001

Stimulus Bill Gives NIH A $10 Billion Boost Over Two Years, Puts Pressure On Institutes to Make Rapid Funding Decisions

February 13, 2009

NCI CTEP Approved Trials For the Month of July

July 26, 2013

House Committee Proposes $750 Mil. Increase For NIH, supports Bypass

May 4, 1990